|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/48 | |
| A61K 9/08 | |||
| A61K 9/19 | |||
| A61K 47/02 | |||
| A61K 47/10 | |||
| A61K 47/18 |
| (11) | Patento numeris | 3167897 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15203085.4 |
| Europos patento paraiškos padavimo data | 2010-09-21 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-05-17 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-01-27 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 244353 P | 2009-09-21 | US |
| (72) |
MATTHIESSEN, H., Peter, AT
TURECEK, Peter, L., AT
SCHWARZ, Hans-Peter, AT
|
| (73) |
Takeda Pharmaceutical Company Limited,
1-1, Doshomachi 4-chome, Chuo-ku,, Osaka-shi, Osaka,
JP
|
| (54) | STABILIZED LIQUID AND LYOPHILIZED ADAMTS13 FORMULATIONS |
| STABILIZED LIQUID AND LYOPHILIZED ADAMTS13 FORMULATIONS |